OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B7-H3: a robust target for immunotherapy in prostate cancer
Rafael Pulido, José I. López, Caroline E. Nunes‐Xavier
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 584-587
Open Access | Times Cited: 7

Showing 7 citing articles:

Histone lactylation-driven B7-H3 expression promotes tumor immune evasion
Zhibo Ma, Jianming Yang, Wenlong Jia, et al.
Theranostics (2025) Vol. 15, Iss. 6, pp. 2338-2359
Open Access | Times Cited: 2

Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Yuhua Zhou, Jing Lv, Shengkai Jin, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1

Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access

Current and future directions in theranostics for neuroendocrine prostate cancer
Gokce Belge Bilgin, Fabrice Lucien, Aadel A. Chaudhuri, et al.
Cancer Treatment Reviews (2025), pp. 102941-102941
Closed Access

Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation
Gang Zhang, Yinfeng Chen, Xing Huang, et al.
Trends in cancer (2024)
Closed Access

Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
Qi Shen, Kaichen Zhou, Hui‐qin Lu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access

Page 1

Scroll to top